Variables Total Metabolic syndrome no (Prevalence) PR 95% CI (PR) p
Ethnicity         0.191
white or Asian 88 23 (26.1) 1    
biracial or black 478 96 (20.1) 0.77 0.52 - 1.14  
Parity         0.020
not applicable (virgins) 84 11 (13.1) 1    
without children 393  80 (20.6) 1.57 0.88 - 2.82  
with children 89  27 (30,3) 2.32 1.22 - 4.37  
Menstrual Irregularity and amenorrhea         0.640
no 59 11 (18.6) 1    
yes 507 108 (21.3+A1:F33) 1.14 0.653 - 2.00  
Hirsutism         0.029
no 46 3 (6.5) 1    
yes 520 116 (22.3) 3.42 1.13 - 10.35  
Hyperandrogenemia         0.807
no 272 56 (20.6) 1    
yes 294 63 (21.4) 1.04 0.76 - 1.43  
Polycystic ovaries         0.900
no 126 27 (21.4) 1    
yes 440 92 (20.9) 0.98 0.67 - 1.43  
Family history of diabetes         0.394
no 38 10 (26.3) 1    
yes 528 109 (20.6) 0.78 0.45 - 1.37  
Family history of hypertension         0.639
no 506 105 (20.7) 1    
yes 60 14 (23.3) 1.12 0.69 - 1.83  
Family history of gynecological cancer     0.329
no 554 118 (21.3) 1    
yes 12 1 (8.3) 0.39 0.06 - 2.58  
Family history of nongynecological cancer     0.704
no 541 113 (20.9) 1    
yes 25 6 (24.0) 1.15 0.56 - 2.35  
Quantitative Variables without Metabolic Risk with Metabolic Risk p*
mean (SD); median (min-max) mean (SD); median (min-max)
Age 26.1 (5.8); 25.0 (14 - 39) 27.7 (6.1); 28.0 (14 - 39) 0.006
BMI (n=308) 27.5 (6.9); 26.9 (16.8 - 59.0) 36.1 (7.8); 34.9 (25.1 - 56.9) <0.001
Menarche 13.0 (1.8); 13 (9 - 18) 12.8 (1.9); 13 (9 - 18) 0.619
Time period (years) of reproductive desire(years) 1.3 (2.2); 0 (0 - 14) 1.9 (3.2); 0 (0 - 16) 0.195
Time period (years) of irregularity (n=437) 6.3 (5.8); 5 (0 - 28) 7.6 (6.3); 5 (0 - 24) 0.101
PR: Prevalence Ratio; SD: standard Deviation
Table 3: Relationship between family comorbidities, clinical and gynecological characteristics and metabolic syndrome. *Mann-Whitney test